60 units of tirzepatide Compounded Tirzepatide BPI Labs - DiversifyRx
Description
#CKD #KidneyHealth #Nephrology #ShoalsKidney #ValueBasedCare

Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.

Physician-owned clinic in Brea, CA GLP-1 weight loss, testosterone therapy, bioidentical hormones & peptides

It's FDA approved for two main uses: chronic weight management in adults with obesity (or overweight plus a weight-related condition), and moderate to severe obstructive sleep apnea (OSA) in adults with obesity

The is 2013 - 2016: It all started with Novartis developing Bimagrumab and receiving an FDA breakthrough designation in August 2013 for sporadic inclusion body myositis.In 2016, it failed a Phase IIb/III trial
